Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric Patients.
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 9, doi. 10.1177/8755122517747088
- By:
- Publication type:
- Article
Works matching IS 87551225 AND DT 2018 AND VI 34 AND IP 1
Results: 6
1
2
Treatment Sequencing in Advanced BRAF-Mutant Melanoma Patients: Current Practice in the United States.
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 17, doi. 10.1177/8755122517747089
- By:
- Publication type:
- Article
3
Monitoring Patients on Metformin: Recent Changes and Rationales.
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 28, doi. 10.1177/8755122517747295
- By:
- Publication type:
- Article
4
Evaluation of Lipid Profile and Residual Cardiovascular Risk in Patients Prior to Initiation of Niaspan Therapy.
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 3, doi. 10.1177/8755122517745650
- By:
- Publication type:
- Article
5
Identifying Missed Opportunities for the Pneumococcal Conjugate Vaccine (PCV13).
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 24, doi. 10.1177/8755122517740364
- By:
- Publication type:
- Article
6
Reviewer Acknowledgment.
- Published in:
- Journal of Pharmacy Technology, 2018, v. 34, n. 1, p. 37, doi. 10.1177/8755122517744031
- Publication type:
- Article